Testing telaglenastat for pulmonary hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests an experimental pill (telaglenastat) for people with various types of pulmonary hypertension (PH). The goal is to see if it can improve exercise ability and heart-pumping function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 75.
- Diagnosed with pulmonary hypertension (high blood pressure in the lungs) by a specialist.
- Able to walk at least 100 meters but less than 550 meters in 6 minutes.
- Your BMI (body mass index) must be between 18 and 40.
- You must have had a right heart catheterization (a test that measures pressures in your heart and lungs) within the past year.
- If you take medications for your lung or heart condition, your dose must have been stable for at least 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new “trial tools” and designs for running early research in people with pulmonary hypertension. If you qualify, you may be asked to do extra trial-related procedures to help researchers test the process safely and smoothly.
This trial tests if pioglitazone, a medicine used for diabetes, can help people with high blood pressure in their lungs caused by chronic lung disease. The goal is to see if it improves how your cells use energy.
This trial tests whether an inhaled medication called treprostinil can improve exercise ability in people with exercise-induced pulmonary hypertension. It aims to see if the drug helps with shortness of breath during activity.
This study tests whether a home-based exercise program, guided by a smartphone app, can improve your daily life and heart function if you have pulmonary hypertension. You will use a wearable device to track your activity and receive remote support from a medical team.
This trial tests whether a structured exercise program, done with remote support, is safe and helpful for children with pulmonary hypertension. It aims to improve how well kids function day-to-day while they stay on their usual PH medications.
This trial tests an inhaled medicine (TPIP) for people with both lung scarring (interstitial lung disease) and high blood pressure in the lungs (pulmonary hypertension). It aims to see if the drug helps improve exercise ability and symptoms.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.